Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the thrombophilia market grown over the years?

The market size of thrombophilia has significantly increased in recent years, expanding from $17.03 billion in 2024 to an estimated $18.35 billion in 2025, at a compound annual growth rate (CAGR) of 7.7%. The exponential growth witnessed throughout the historical period can be traced back to factors such as heightened awareness, developments in anti-coagulant treatments, an aging worldwide population, advances in genetic research, and a rising incidence of thrombotic disorders.

What Is the forecasted market size and growth rate for the thrombophilia market?

Significant escalation is anticipated in the thrombophilia market size in the approaching years. It is projected to escalate to $25.12 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.2%. The forecast period’s growth can be credited to various factors such as personalized medicine, the emergence of innovative treatments, the application of artificial intelligence, healthcare directives, and enhanced patient awareness and empowerment. Some significant trends during the forecast period include technological progression, the amplified application of telemedicine, increasing occurrence rates, developments in biopharmaceutical, and cooperative research efforts.

Get your thrombophilia market report here!

https://www.thebusinessresearchcompany.com/report/thrombophilia-global-market-report

What are the major factors driving growth in the thrombophilia market?

The growth of the thrombophilia market is predicted to escalate due to the projected rise in the elderly population. The term elderly population is used to denote individuals who are 65 years old and above. Their portion in the dependent population is gauged by calculating the total number of elderly and young individuals in comparison to the entire population. In older adults, the prevalence of thrombophilic risk factors is quite common and aids in identifying those at risk for severe clinical results. Therefore, an increase in the elderly population will enhance the market by generating demand for thrombophilia drugs. For example, America’s Health Rankings, a US organization that assesses health outcomes, disclosed in 2022 that more than 56 million adults 65 and older make up approximately 16.9% of the whole US population, with expectations of this number rising to over 73.1 million by 2030. Consequently, the expansion of the elderly population is facilitating the growth of the thrombophilia market.

What key areas define the segmentation of the global thrombophilia Market?

The thrombophilia market covered in this report is segmented –

1) By Type: Factor V Leiden, Prothrombin 20210, Antiphospholipid Syndrome, Other Type

2) By Drugs: Heparin, Warfarin, Other Drugs

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration

4) By End-Users: Hospitals, Homecare, Specialty Centers, Other End Users

Subsegments:

1) By Factor V Leiden: Genetic Testing, Anticoagulant Therapy

2) By Prothrombin 20210: Genetic Testing, Anticoagulant Therapy

3) By Antiphospholipid Syndrome: Antiphospholipid Antibody Testing, Anticoagulant Therapy

4) By Other Types: Protein C Deficiency, Protein S Deficiency, Antithrombin III Deficiency, Other Genetic Conditions

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9439&type=smp

What are the top market players propelling the growth of the thrombophilia industry?

Major companies operating in the thrombophilia market include Pfizer Inc., F. Hoffmann-La Roche Limited, Changzhaou Qianhong Bio-pharma Co. Limited, Fresenius Kabi AG, Hebei Changshan Biochemical Pharmaceutical Co. Limited, Hikma Pharmaceuticals PLC., Novartis AG, Shanghai Fosun Pharmaceutical (Group) Co. Ltd., Shenzhen Hepalink Pharmaceutical Group Co. Limited, Teva Pharmaceutical Industries Limited, Yino Pharma Limited, Sanofi SA, Eisai Co. Limited, Boehringer Ingelheim GmbH, Instrumentation Laboratory SpA, Johnson & Johnson, Laurus Lab, Bristol-Myers Squibb, Roche, Abbott, C. H. Boehringer Sohn, Portola Pharmaceuticals, Daiichi Sankyo, Bayer Group, GlaxoSmithKline plc, CSL Behring

What are the key trends shaping the future of the thrombophilia market?

The key emerging trend in the thrombophilia market is technological innovation. Major market players are focusing on the development of new technologies to maintain their market dominance. For instance, in May 2023, a revolutionary technology called Eloctate was developed by researchers at the University of California, San Diego. This cutting-edge technology uses an innovative fusion protein to increase the stability and half-life of coagulation factors in the bloodstream. The aim of the researchers is to combine this technology with existing treatments to develop longer-lasting drugs that require less frequent administration, ultimately enhancing patient adherence and quality of life.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9439

What regions are dominating the thrombophilia market growth?

North America was the largest region in the thrombophilia market in 2024. The regions covered in the thrombophilia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: